Compare Rigetti Computing Inc (RGTI) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rigetti Computing Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Rigetti Computing Inc trades at $14.03 (market cap $4.72B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 12.4× Rigetti Computing Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rigetti Computing Inc for 35 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| RGTI | TAK | |
|---|---|---|
Market Cap | $4.72B | $58.74B |
Volume | 17,136,381 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $56.34 | $19.05 |
52-Week Low | $12.90 | $13.23 |
Typical Hold Time | 35 Days | 1 Days |
Enterprise Value | $4.33B | $86.65B |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGTI trades at $14.14, down 3.08% today, amid bearish technical signals despite bullish oscillators. The company shows negative profitability with a -1,787.4% net income margin and -$216.21M net loss for 2025, though revenue grew to $13M in 2026. Recent news highlights Rigetti's hybrid quantum-HPC strategy advancements and sector momentum from IonQ's developments.
Wall Street maintains strong bullish sentiment with 6 buy ratings and a $21.67 price target, representing 53% upside. However, significant execution risks persist given negative cash flow, high valuation multiples, and intense quantum computing competition. The stock offers high-risk growth potential for investors comfortable with speculative emerging technology plays.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
